Doximity (DOCS) Q1 FY27 earnings call

Doximity delivered strong Q1 FY27 results, driven by reaccelerated revenue growth and robust adoption of its AI tools, particularly Doximity Ask, which demonstrated leading accuracy in independent studies. The company is strategically increasing AI investments to capitalize on significant long-term opportunities, focusing on enhancing its clinical AI suite and expanding commercialization efforts, despite near-term impacts on gross margin and FCF.